Bon Secours Health System

bonsecours.com

Bon Secours Health System, Inc. based in Marriottsville, Maryland, is a $3.2 billion dollar not-for-profit Catholic health system that owns, manages or joint ventures 18 acute care, 5 long term care, 4 assisted living, 6 retirement communities/senior housing, 14 home care and hospice services, and other facilities, primarily on the East Coast. Bon Secours Health System consists of more than 24,000 caregivers helping people in seven states. Its vision is to be a prophetic Catholic health ministry partnering with communities to create a more humane world, build health and social justice and provide exceptional value for those served.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

news image

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More

USA TO DO A CLINICAL TEST OF THE JAPANESE ANTI-FLU DRUG AVIGAN TO TREAT THE PATIENTS SUFFERING FROM CORONAVIRUS

Clout News | April 12, 2020

news image

The number of positive cases of coronavirus are on a rising spree all over the world. The confirmed cases of COVID-19 on a global scale have crossed 1.7 million with the death toll crossing 1,08,000. The most affected country because of coronavirus is the United States of America. With around 5,33,378 positive cases in USA, its death toll has reached more than 20,600 leaving Italy’s death toll behind. According to the reports, USA recorded over 2,000 deaths because of COVID-19. The country...

Read More

Pharma Tech

GINKGO BIOWORKS AND CENTRIENT PHARMACEUTICAL ANNOUNCE EXPANSION OF PARTNERSHIP FOLLOWING SUCCESS OF INITIAL PROJECT TO BRING INNOVATION TO GENERIC API

PR Newswire | May 26, 2023

news image

Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and anti-fungals, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced they are expanding their existing partnership aimed at broadening Centrient's portfolio of environmentally friendly active pharmaceutical ingredients (APIs), following the success of previous work togethe...

Read More

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

news image

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More
news image

Business Insights

AQUESTIVE THERAPEUTICS RECEIVES FDA TENTATIVE APPROVAL FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM

Aquestive Therapeutics, Inc. | August 31, 2022

Aquestive Therapeutics, Inc. a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the U.S. Food & Drug Administration has granted tentative approval for Libervant™ Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern in patients with epileps...

Read More
news image

USA TO DO A CLINICAL TEST OF THE JAPANESE ANTI-FLU DRUG AVIGAN TO TREAT THE PATIENTS SUFFERING FROM CORONAVIRUS

Clout News | April 12, 2020

The number of positive cases of coronavirus are on a rising spree all over the world. The confirmed cases of COVID-19 on a global scale have crossed 1.7 million with the death toll crossing 1,08,000. The most affected country because of coronavirus is the United States of America. With around 5,33,378 positive cases in USA, its death toll has reached more than 20,600 leaving Italy’s death toll behind. According to the reports, USA recorded over 2,000 deaths because of COVID-19. The country...

Read More
news image

Pharma Tech

GINKGO BIOWORKS AND CENTRIENT PHARMACEUTICAL ANNOUNCE EXPANSION OF PARTNERSHIP FOLLOWING SUCCESS OF INITIAL PROJECT TO BRING INNOVATION TO GENERIC API

PR Newswire | May 26, 2023

Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and anti-fungals, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced they are expanding their existing partnership aimed at broadening Centrient's portfolio of environmentally friendly active pharmaceutical ingredients (APIs), following the success of previous work togethe...

Read More
news image

PHARMACY MARKET, PHARMA TECH

KINDEVA DRUG DELIVERY, CHIESI GROUP, AND H&T PRESSPART ANNOUNCE STRATEGIC PARTNERSHIP FOR DOSE COUNTER TECHNOLOGY PRODUCTION

Businesswire | July 12, 2023

Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp & Thumann Group), a market leader in respiratory drug delivery systems design, development, and manufacturing, are partnering with Chiesi Group, an international research-focused biopharmaceutical and healthcare group, for the installation of a production line for dose counter (DC) and dose indicator (DI) devices. Comb...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us